Stacy Petersen
Family · Costa Mesa, CANPI 1144719527
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (40.3%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Pfizer accounts for 78.5% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2023 at $6,636 and has fallen 95.8% since, to $279 in 2025. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 102 payments — averaging $79.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- AbbVie$675
- Aspira Women's Health Inc$172
- Sumitomo Pharma America, Inc.$160
- Biogen$143
- Astellas Pharma US Inc$65
- plus $525 from 15 others
What the payments were for
- Consulting fees$2,80035%
- Travel & lodging$3,26840%
- Food & beverage$1,95324%
- Education$651%
- Gifts$160%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 15 | $6,361 |
| AbbVie | 37 | $675 |
| Aspira Women's Health Inc | 9 | $172 |
| Sumitomo Pharma America, Inc. | 8 | $160 |
| Biogen | 6 | $143 |
| Astellas Pharma US Inc | 1 | $65 |
| Daiichi Sankyo Inc. | 3 | $63 |
| Hologic Sales And Service, LLC | 3 | $60 |
| Ascend Therapeutics US, LLC | 3 | $51 |
| Distalmotion US | 1 | $51 |
| Mayne Pharma Commercial LLC | 4 | $46 |
| Shield Therapeutics Inc | 2 | $40 |
| Evofem Biosciences, Inc. | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $29 |
| Femselect Inc. | 1 | $25 |
| GSK | 1 | $24 |
| Millicent US Inc | 1 | $24 |
| Organon | 1 | $22 |
| Minerva Surgical, Inc | 1 | $19 |
| Exeltis, USA Inc. | 1 | $17 |
| Bayer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$3,175
- Orilissa$124
- ORIAHNN$124
How this compares
$8,102 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 13 | $2,757 |
| Estradiol | 37 | $2,693 |
| Estradiol (Twice Weekly)Estradiol | 17 | $2,095 |
| ProgesteroneProgesterone, Micronized | 11 | $269 |
| Alendronate Sodium | 13 | $64 |
Paid to pharmacies, not to this prescriber.
Other family in Costa Mesa
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.